Cargando…

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?

Detalles Bibliográficos
Autores principales:	Linz, Dominik, Dobrev, Dobromir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465768/ https://www.ncbi.nlm.nih.gov/pubmed/31016225 http://dx.doi.org/10.1016/j.ijcha.2019.100360

Ejemplares similares

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2021)

Sleep apnea and atrial fibrillation: Update 2020
por: Linz, Dominik, et al.
Publicado: (2020)

Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019)

Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2020)

Does weight matter in cryoballoon ablation?
por: Gawałko, Monika, et al.
Publicado: (2023)

Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge
por: Linz, Dominik, et al.
Publicado: (2021)

Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction
por: Linz, Dominik, et al.
Publicado: (2019)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs?
por: Linz, Dominik, et al.
Publicado: (2018)

A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemic
por: Linz, Dominik, et al.
Publicado: (2021)

Recent highlights on the prevalence and role of sleep disordered breathing in cardiovascular diseases from the International Journal of Cardiology Heart & Vasculature
por: Linz, Dominik, et al.
Publicado: (2023)

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
por: Sutanto, Henry, et al.
Publicado: (2019)

Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2022)

Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2020)

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
por: Gawałko, Monika, et al.
Publicado: (2020)

Botulinum toxin for prevention of post-operative atrial fibrillation
por: Saljic, Arnela, et al.
Publicado: (2023)

Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study
por: Havranek, Stepan, et al.
Publicado: (2023)

Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomised study
por: Havranek, S, et al.
Publicado: (2023)

Impact of pulmonary hypertension in patients undergoing atrial fibrillation ablation: A nationwide study
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019)

Central sleep apnea in atrial fibrillation: Risk factor or marker of untreated underlying disease?
por: Linz, Dominik, et al.
Publicado: (2020)

Pulmonary vein remodeling in hypertension: Mechanistic insight into primary prevention of atrial fibrillation
por: Iwasaki, Yu-ki
Publicado: (2018)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2023)

Hypnotic communication during atrial fibrillation ablation: Another clinical application of hypnotherapy?
por: den Uijl, Dennis W., et al.
Publicado: (2019)

Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Hypertension
por: Rottlaender, Dennis, et al.
Publicado: (2012)

Paroxysmal Atrial Fibrillation Catheter Ablation of Pulmonary Veins: does Anatomy Influence the Outcome?
por: Sarabanda, Álvaro Valentim Lima
Publicado: (2018)

Pulmonary arterial hypertension in adults with atrial septal defect
por: Toyono, Manatomo
Publicado: (2012)

Pulmonary Vein Stenosis and Pulmonary Hypertension Following a Catheter-Based Radiofrequency Ablation for Atrial Fibrillation: A Case Report
por: Thomas, Christopher A., et al.
Publicado: (2020)

Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy
por: Havranek, Stepan, et al.
Publicado: (2020)

Risk profiling in atrial fibrillation: Value of assessment of vascular blush
por: Khokhar, Kashif B., et al.
Publicado: (2019)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Pulmonary Hypertension
por: Basyigit, Ilknur, et al.
Publicado: (2012)

Recurrence of atrial fibrillation following non-cardiac surgery or acute illness: A common but rarely detected complication
por: Barrios Espinosa, Cristian, et al.
Publicado: (2020)

Improving patient outcomes in pulmonary hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2015)

Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2012)

Atrial Septal Defect with Down Syndrome and Postsurgical Pulmonary Hypertension
por: Yoon, Kyung Lim
Publicado: (2019)

High-power short-duration ablation: The new standard for pulmonary vein isolation?
por: Chaldoupi, Sevasti-Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_56rg1jrplk4gheg2pbghm42ohh